Adaptive Biotechnologies Corp — Director's Dealing 2020

Feb 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2020-02-13

Reporting Person: SANG CHARLES (SVP, Clinical Diagnostics)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-13	Stock Option (Right to Buy)	$31.71	A	40000	Acquired	2030-02-13	Common Stock (40000)	Direct

Footnotes

F1: The options vest with respect to 1/4 of such shares on February 13, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.